Technical Analysis
Comprehensive insights into market trends, chart patterns, and key indicators. Equip yourself with the tools and strategies to make data-driven trading decisions.
Bitcoin dips below $100,000 after the Federal Reserve signaled fewer interest rate cuts than expected. This drop impacts speculative investments like Bitcoin, reflecting a shift away from riskier assets due to higher interest rates.
Bitcoin Dips Below $100,000 as Fed Signals Fewer Rate Cuts Read More »
Inditex Q3 sales missed expectations despite strong holiday sales, impacted by currency and flooding in Spain. While profits are up, analysts note a slowdown and potential future risks from tariffs and inflation.
Inditex Q3 Sales Miss Expectations Despite Strong Holiday Start Read More »
US Treasury yields fell after inflation data came in below expectations, fueling speculation of Fed rate cuts in 2025. Market pricing suggests fewer cuts than many analysts predict, creating uncertainty around future Fed policy.
US Treasury Yields Fall as Inflation Cools, Sparking Fed Rate Cut Expectations Read More »
A new pandemic could cost the global economy $13.6 trillion over five years, according to Lloyd’s of London. This analysis highlights the urgent need for pandemic preparedness and effective risk management strategies.
Pandemic Could Cost Global Economy $13.6 Trillion: Lloyd’s of London Read More »
Americans are wary of Trump’s proposed tariffs, with a new Reuters/Ipsos poll showing only 29% support higher prices from import taxes. Most doubt tariffs will benefit them, raising concerns about Trump’s economic agenda.
Americans Skeptical of Trump’s Tariff Plan, Reuters/Ipsos Poll Reveals Read More »
Top AI stocks for 2025: Discover two promising buys (Alphabet and Alibaba) poised for growth, and one AI stock to avoid due to overvaluation. Learn why these picks are crucial for strategic AI investment.
Top AI Stocks for 2025: 2 Promising Buys and 1 to Avoid Read More »
ARCH-backed weight-loss drug developer Metsera files for IPO despite widening losses, aiming to capitalize on the booming obesity treatment market. The biotech company seeks funding to advance its lead GLP-1 drug candidate, MET-097i, into further clinical trials.
Metsera, ARCH Venture-Backed Weight-Loss Drug Developer, Files for IPO Read More »
Oracle’s Q2 cloud revenue met expectations, but failed to surpass them, triggering an 8.5% stock drop after recent record highs. While cloud infrastructure saw 52% growth, other metrics missed projections, raising concerns about competition and regulatory risks.
Oracle Stock Plunges After Cloud Revenue Meets Expectations Read More »
Honda-Nissan merger: S&P predicts a long road to realizing benefits. Integrating distinct strategies and navigating overlapping markets like North America and China pose significant challenges.
Honda-Nissan Merger: Long Road to Realization, Says S&P Read More »
Walgreens Boots Alliance faces major hurdles in a potential take-private deal due to its size and the challenging financing market. Regulatory scrutiny and complex integration processes add further complications, making a successful acquisition uncertain.
Walgreens Boots Alliance Faces Hurdles in Potential Take-Private Deal Read More »
